share_log

DA32 Life Science Tech Acquisition (NASDAQ:DALS) Trading 0.3% Higher

DA32 Life Science Tech Acquisition (NASDAQ:DALS) Trading 0.3% Higher

DA32生命科學技術收購(納斯達克:DALS)上漲0.3%
Financial News Live ·  2022/10/28 15:51

DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS – Get Rating) shares traded up 0.3% during trading on Wednesday . The company traded as high as $9.80 and last traded at $9.80. 20,429 shares traded hands during trading, a decline of 75% from the average session volume of 82,249 shares. The stock had previously closed at $9.77.

DA32生命科學技術收購公司(納斯達克代碼:DALS-GET Rating)的股票週三在交易中上漲0.3%。該公司股價一度高達9.80美元,最新報9.80美元。當日有20,429股股票成交,較82,249股的平均成交量下降75%。該股此前收盤價為9.77美元。

DA32 Life Science Tech Acquisition Stock Performance

DA32生命科學技術收購股票表現

The stock has a 50 day moving average of $9.74 and a 200 day moving average of $9.72.

該股的50日移動均線切入位為9.74美元,200日移動均線切入位為9.72美元。

Get
到達
DA32 Life Science Tech Acquisition
DA32生命科學技術收購
alerts:
警報:

Institutional Inflows and Outflows

機構資金流入和流出

Institutional investors and hedge funds have recently modified their holdings of the business. Spartan Fund Management Inc. bought a new position in shares of DA32 Life Science Tech Acquisition in the first quarter worth $181,000. Ursa Fund Management LLC bought a new position in shares of DA32 Life Science Tech Acquisition in the first quarter worth $243,000. Piper Sandler & CO. acquired a new stake in shares of DA32 Life Science Tech Acquisition in the first quarter valued at $244,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new stake in shares of DA32 Life Science Tech Acquisition in the first quarter valued at $486,000. Finally, Fir Tree Capital Management LP acquired a new stake in shares of DA32 Life Science Tech Acquisition in the first quarter valued at $758,000. Institutional investors own 60.43% of the company's stock.

機構投資者和對衝基金最近調整了對該公司的持股。斯巴達基金管理公司在第一季度購買了價值181,000美元的DA32生命科學技術收購的新股票頭寸。Ursa Fund Management LLC在第一季度購買了DA32 Life Science Tech收購的新股票頭寸,價值24.3萬美元。派珀·桑德勒公司在第一季度收購了DA32生命科學技術收購的新股份,價值244,000美元。賓夕法尼亞州聯邦公立學校Empls Retrmt Systems在第一季度收購了DA32生命科學技術公司的新股份,價值486,000美元。最後,Fir Tree Capital Management LP在第一季度收購了DA32生命科學技術收購公司的新股份,價值75.8萬美元。機構投資者持有該公司60.43%的股份。

DA32 Life Science Tech Acquisition Company Profile

DA32生命科學技術收購公司簡介

(Get Rating)
(獲取評級)

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors.

DA32生命科學技術收購公司沒有重大業務。它側重於與一個或多個企業進行合併、資本換股、資產收購、股票購買、重組或相關業務合併。該公司打算確定生物技術和生命科學基礎設施領域的業務合併目標。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on DA32 Life Science Tech Acquisition (DALS)
  • McDonald's Stock Sizzles, but Will it Hit a New All-Time High?
  • Why is Amazon Stock Falling? Is the Sell-Off Overdone?
  • Will Ryanair Stock Gains, Strong Estimates Help it Fly?
  • Can Comcast Monetize Existing Users for Streaming Success?
  • Apple Inc. Stock Q4 Results Beat Negative Outlook, Stock Rises
  • 免費獲取StockNews.com關於DA32生命科學技術收購(DALS)的研究報告
  • 麥當勞股價下跌,但它會創下歷史新高嗎?
  • 為什麼亞馬遜的股票會下跌?拋售是否過頭了?
  • 瑞安航空股價上漲,強勁的預期是否會幫助它飛起來?
  • 康卡斯特能否通過流媒體的成功將現有用户貨幣化?
  • 蘋果。第四季度業績好於負面預期,股價上漲

Receive News & Ratings for DA32 Life Science Tech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DA32 Life Science Tech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

獲得DA32生命科學技術收購日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對DA32生命科學技術收購和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論